Get started
Organon & Co.Organon & Co.Organon & Co.

Organon & Co.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

OGN chart


Full chart

OGN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.65 B‬ USD
Dividend yield (indicated)
6.20%
Price to earnings Ratio (TTM)
3.58
Basic EPS (TTM)
5.07 USD
Net income (FY)
‪1.02 B‬ USD
Revenue (FY)
‪6.26 B‬ USD
Shares float
‪256.91 M‬
Beta (1Y)
0.23

Employees


Employees (FY)
‪10 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪626.30 K‬ USD
Net income / Employee (1Y)
‪102.30 K‬ USD

About Organon & Co.


Sector
Health Technology
CEO
Kevin Ali
Headquarters
Jersey City
Website
organon.com
Founded
2020
FIGI
BBG00ZQRGW24
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

OGN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

OGN highest yielding bonds


MRK5808585
Organon & Co. 7.875% 15-MAY-2034
Yield to maturity
7.24%
Maturity date
May 15, 2034
MRK5164077
Organon Finance 1 LLC 5.125% 30-APR-2031
Yield to maturity
6.80%
Maturity date
Apr 30, 2031
MRK5808583
Organon & Co. 6.75% 15-MAY-2034
Yield to maturity
6.68%
Maturity date
May 15, 2034
MRK5164075
Organon Finance 1 LLC 4.125% 30-APR-2028
Yield to maturity
5.32%
Maturity date
Apr 30, 2028
XS233225070
ORGANON/ORG.F. 21/28 REGS
Yield to maturity
3.93%
Maturity date
Apr 30, 2028

Explore more bonds 

Frequently Asked Questions


The current price of OGN is 16.92 USD — it has decreased by −6.36% in the past 24 hours. Watch Organon & Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Organon & Co. stocks are traded under the ticker OGN.
OGN stock has fallen by −2.53% compared to the previous week, the month change is a −8.04% fall, over the last year Organon & Co. has showed a 27.41% increase.
We've gathered analysts' opinions on Organon & Co. future price: according to them, OGN price has a max estimate of 30.00 USD and a min estimate of 17.00 USD. Watch OGN chart and read a more detailed Organon & Co. stock forecast: see what analysts think of Organon & Co. and suggest that you do with its stocks.
OGN reached its all-time high on Mar 2, 2022 with the price of 39.48 USD, and its all-time low was 10.84 USD and was reached on Dec 6, 2023. View more price dynamics on OGN chart.
See other stocks reaching their highest and lowest prices.
OGN stock is 7.46% volatile and has beta coefficient of 0.23. Track Organon & Co. stock price on the chart and check out the list of the most volatile stocks — is Organon & Co. there?
Today Organon & Co. has the market capitalization of ‪4.36 B‬, it has increased by 4.12% over the last week.
Yes, you can track Organon & Co. financials in yearly and quarterly reports right on TradingView.
Organon & Co. is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
OGN earnings for the last quarter are 0.87 USD per share, whereas the estimation was 0.90 USD resulting in a −3.70% surprise. The estimated earnings for the next quarter are 0.93 USD per share. See more details about Organon & Co. earnings.
Organon & Co. revenue for the last quarter amounts to ‪1.58 B‬ USD, despite the estimated figure of ‪1.56 B‬ USD. In the next quarter, revenue is expected to reach ‪1.59 B‬ USD.
OGN net income for the last quarter is ‪359.00 M‬ USD, while the quarter before that showed ‪195.00 M‬ USD of net income which accounts for 84.10% change. Track more Organon & Co. financial stats to get the full picture.
Yes, OGN dividends are paid quarterly. The last dividend per share was 0.28 USD. As of today, Dividend Yield (TTM)% is 6.62%. Tracking Organon & Co. dividends might help you take more informed decisions.
Organon & Co. dividend yield was 7.77% in 2023, and payout ratio reached 28.06%. The year before the numbers were 4.01% and 31.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪10.00 K‬ employees. See our rating of the largest employees — is Organon & Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organon & Co. EBITDA is ‪1.76 B‬ USD, and current EBITDA margin is 24.96%. See more stats in Organon & Co. financial statements.
Like other stocks, OGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organon & Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organon & Co. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organon & Co. stock shows the sell signal. See more of Organon & Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.